Skip to main content

Table 1 Tumor markers and hormonal evaluation at baseline, after surgery, and in the follow-up

From: Leydig cell tumors of the testis: a case report

 

2 y

Before

After

1 y

2 y

3 y

4 y

Normal range for age

 

Eralier

Surgery

Surgery

After surgery

After surgery

After surgery

After surgery

 

AFP, ng/ml

2.26

1.80

2.88

2.16

3.46

2.68

3.20

< 44

β-hCG, mIU/ml

0.10

0.06

0.09

0.08

0.20

0.16

0.13

0.5-2.67

Total testosterone, ng/ml

4.23

1.80

2.40

4.60

6.26

6.60

4.40

1.75-7.81

Estradiol, pg/ml

26.31

80.22

61.31

78.4

62.43

75.56

78.96

< 47

LH, mIU/ml

5.34

1.76

2.40

4.58

5.32

3.67

4.84

1.24-8.62

FSH, mIU/ml

4.23

3.80

2.49

2.80

4.12

2.74

3.85

1.27-19.26

17-KS, mg/24 hours

23.4

17.9

18.75

18.8

22.3

19.6

21.4

17-25

17-HOCS, mg/24 hours

8.4

10.22

9.07

8.8

7.40

9.22

8.94

2-10

Progesterone, ng/ml

-

-

0.09

-

-

-

-

0.10-0.84

TSH, μUI/ml

-

3.14

2.9

2.5

-

-

-

0.5-4.5

  1. Abbreviations: AFP alpha-fetoprotein, β-hCG β-human chorionic gonadotropin, FSH follicle-stimulating hormone, LH luteinizing hormone, 17-KS urinary 17-ketosteroids, 17-HOCS urinary 17-hydroxycorticosteroid, TSH Thyroid-stimulating hormone.